2nd Quarter - Report

THORN RUN PARTNERS for SUNOVION PHARMACEUTICALS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

DEA scheduling of pharmaceuticals

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Veterans VET

Funding issues related to the VA Epilepsy Centers for Excellence.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Medicare Part D, Medicaid reform, mental and neurological health issues.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.